ACA
JNJ icon

Aptus Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Aptus Capital Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,200,000
Closed -$174M – 1468
2024
Q4 		$174M Buy
+1,200,000
New +$186M 1.82% 7
2019
Q2 		– Sell
-762
Closed -$474K – 350
2019
Q1 		$474K Buy
+762
New +$102K 0.08% 196

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aptus Capital Advisors's JNJ Position: Q1 2026 in Review

Aptus Capital Advisors reduced its Johnson & Johnson (JNJ) stake by 3.1% in Q1 2026, selling an estimated $1.42M and leaving 193,144 shares worth $47.2M. The position accounts for 0.37% of the portfolio, ranked #55.

Aptus Capital Advisors first reported a position in JNJ in Q1 2019 and has held it in 29 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Aptus Capital Advisors held 193,144 shares of Johnson & Johnson worth $47.2M as of Q1 2026.
  • Aptus Capital Advisors sold 6,081 Johnson & Johnson shares in Q1 2026, an estimated $1.42M.
  • Johnson & Johnson made up 0.37% of Aptus Capital Advisors's portfolio in Q1 2026, its #55 holding.
  • Aptus Capital Advisors first reported a position in Johnson & Johnson in Q1 2019 and has held it in 29 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Aptus Capital Advisors's 13F filing for Q1 2026, filed 11 May 2026.